Adtalem Global Education Inc. (ATGE)
- Previous Close
112.81 - Open
115.25 - Bid 115.78 x 900
- Ask 116.00 x 1400
- Day's Range
114.23 - 116.69 - 52 Week Range
61.65 - 116.69 - Volume
192,832 - Avg. Volume
491,175 - Market Cap (intraday)
4.322B - Beta (5Y Monthly) 0.86
- PE Ratio (TTM)
22.09 - EPS (TTM)
5.25 - Earnings Date May 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Nov 30, 2016
- 1y Target Est
123.50
Adtalem Global Education Inc. engages in the provision of workforce solutions worldwide. It operates through three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees, as well as online certificates in the medical, nursing, health professions and veterinary postsecondary education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice industries. It operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as DeVry Education Group Inc. and changed its name to Adtalem Global Education Inc. in May 2017. Adtalem Global Education Inc. was incorporated in 1987 and is based in Chicago, Illinois.
www.adtalem.com4,624
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: ATGE
View MorePerformance Overview: ATGE
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATGE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATGE
View MoreValuation Measures
Market Cap
4.20B
Enterprise Value
4.87B
Trailing P/E
21.49
Forward P/E
15.67
PEG Ratio (5yr expected)
1.04
Price/Sales (ttm)
2.60
Price/Book (mrq)
2.92
Enterprise Value/Revenue
2.89
Enterprise Value/EBITDA
12.34
Financial Highlights
Profitability and Income Statement
Profit Margin
12.34%
Return on Assets (ttm)
7.48%
Return on Equity (ttm)
14.63%
Revenue (ttm)
1.69B
Net Income Avi to Common (ttm)
205.46M
Diluted EPS (ttm)
5.25
Balance Sheet and Cash Flow
Total Cash (mrq)
193.96M
Total Debt/Equity (mrq)
60.09%
Levered Free Cash Flow (ttm)
211.94M